Form Type: 4

SEC EDGAR Link
Accession Number:0001567619-19-018505
Date:2019-09-17
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
Original Submission Date:

Reporting Person:

LAWLIS V BRYAN
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE NOVATO, CA 94949

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-09-17 M 3,750 a $21.51 27,340 direct
COMMON STOCK 2019-09-17 S 3,750 d $74.47 23,590 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY COMMON STOCK) 21.51 2019-09-17 deemed execution date M 3,750 (d) 2010-11-12 2020-05-11 common stock 3,750 $21.51 7,500 direct
Footnotes
IDfootnote
f1 trade made pursuant to a 10b5-1 plan executed on may 1, 2019.
f2 reflects the number of options outstanding after the transactions from the specific stock option grant.
WhaleWisdom Logo

Elevate your investments